Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
duloxetine hydrochloride, Quantity: 67.3 mg
Alembic Pharmaceuticals Australia Pty Ltd
Duloxetine hydrochloride
Capsule, enteric
Excipient Ingredients: Gelatin; sucrose; hypromellose; triethyl citrate; purified talc; hypromellose phthalate; titanium dioxide; indigo carmine; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; ethanol absolute; ammonia; potassium hydroxide; maize starch
Oral
28 capsules
(S4) Prescription Only Medicine
Duloxetine capsules are indicated for the treatment of major depressive disorder (MDD).,Treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Treatment of Generalised Anxiety Disorder (GAD).
Visual Identification: Opaque blue/opaque green hard gelatin capsule '158' on body and 'A' on cap with white ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2013-06-14